BBP

BioShares Biotechnology Products Fund

The BioShares Biotechnology Products Fund seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Products Index.


Rules-Based, Semi-Diverse

MANAGEMENT MATRIX

FBT

CLOSEST COMP

FACTOR SCORECARD

SIZE
VALUE
YIELD
MOMENTUM
VOLATILITY
QUALITY
Fund Basics
Fund sponsorETFis Capital LLC
CategoryUS Equities
Asset classEquity
Websitelink...
Inception dateDec 16, 2014
Assets (mns)$18
Expense ratio79 bp
CurrencyUSD
Sector Breakdown
Fund Structure
RegulationOpen-End Investment Company
DistributionsAnnually
Taxation1099
Stock selectionProprietary
WeightingEqual
Holdings TransparencyFull
Derivatives-basedNo
Options availableYes
Currency hedgedNo
Fund of fundsNo
Top 10 Holdings
MYOVANT SCIENCES LTD. 3.9 %
AXSOME THERAPEUTICS, INC. 3.8 %
IMMUNOCORE HOLDINGS PLC SPONSORED ADR 3.4 %
KINIKSA PHARMACEUTICALS LTD. CLASS A 2.9 %
SAREPTA THERAPEUTICS INC 2.7 %
AGIOS PHARMACEUTICALS INC 2.6 %
ALNYLAM PHARMACEUTICALS INC 2.4 %
BIOGEN IDEC INC 2.4 %
PTC THERAPEUTICS INC 2.3 %
GILEAD SCIENCES INC 2.3 %
Constituent Breakdown
Number of holdings51
Herfindahl-Hirschman Index 213
Wgt avg mkt cap (mns)$15,356
Large cap (>$10bn)27.2%
Mid cap ($2-10bn)41.9%
Small cap (<$2bn)31.0%
Developed mkts.98.5%
Emerging mkts.1.5%
Country Exposure
UNITED STATES 75.9 %
BRITAIN 9.4 %
CHINA 4.0 %
BERMUDA 2.9 %
DENMARK 2.2 %
CAYMAN ISLANDS 1.9 %
GERMANY 1.7 %
CANADA 0.8 %
Historical Performance


Standardized Annual Returns (as of 11/30/2022)
YTD1 YR2 YR3 YR5 YR10 YRIncep.
1.7% 4.1% -1.4% 4.4% 4.8% -- 8.8%
Market Correlations
versus...BetaR-squared
S&P 5000.5125%
MSCI EAFE0.4923%
MSCI Emg Mkts0.5229%
Liquidity Measures
Avg. volume (000)1
Turnover0.3%
Avg. Bid/Ask (% of price)0.26%
ADV of underlying (mns)$7,107
Technical Indicators
Recent close$50.15
30d moving avg.$47.39
Annualized volatility21.3%
Relative strength (RSI)60
Short interest (ETF)0.1%
Short interest (underlying)10.0%
Distributions
Assets Under Management (mns)

Money Flows (mns)

Short Interest (as % of shares outstanding)

Long Money Flows (mns)

Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial

Risk and Returns: BBP vs. Comps (1 YR)

Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.

Content on this tab for Individual & Professional subscribers only. Start your FREE trial

Results & Estimates
  2017 2018 2019 2020 2021 2022E 2023E  
Sales per share -- -- -- -- -- -- --
  change (%) -- -- -- -- -- -- --
Earnings per share -- -- -- -- -- -- --
  change (%) -- -- -- -- -- -- --
Dividends per share -- -- -- -- -- -- --
  change (%) -- -- -- -- -- -- --
Book value per share -- -- -- -- -- -- --
  change (%) -- -- -- -- -- -- --
Return on Equity
Net Margins
EPS Revision Activity (6 mo. ago = 100%)
Compound Annual Growth Rates

Content on this tab for Individual & Professional subscribers only. Start your FREE trial

Valuation Metrics
  2021 2022E Fwd Est 2023E
Price-to-sales --x --x --x --x
Price-to-earnings --x --x --x --x
Price-to-cash flow --x --x --x --x
Price-to-growth --x --x --x --x
Price-to-book value --x --x --x --x
Yield --% --% --x --%
7.0 -20.0 25.9 0.2% --
Based on closing prices from 11/30/2022
Historical Valuation Trends Sample data. Subscribe for access.

SHOWING:
Price-to-Earnings
BBP



Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.

Some content on this tab for Individual & Professional subscribers only. Start your FREE trial

ETF Research Center Fund Rating

Our measure of an ETF's overall investment merit

ALTAR Score™

BBP

-2.3%

Cat. Avg

6.3%

Fund Category: US Equities

Avg. Return on Equity--%
Divided by: Fwd. P/BV--x
Less: Expenses-- bp
Equals: ALTAR Score™-2.3%
Recommendation

AVOID

Not worthwhile for most investors. A rating of AVOID is assigned to ETFs with ALTAR Scores in the lowest quintile (the bottom 20%) of their category. Often, funds in this category consist of stocks with little if any history or expectation of profitability, and as a result our fundamentally-driven analysis may be less relevant.

Category Overview
There are 876 funds in the US Equities category, with an average ALTAR Score™ of 6.3% and a standard deviation of 3.0%. BBP's ALTAR Score™ is approximately 2.9 standard deviations below the category average. This places BBP in the 1st percentile among funds in the category.
Consensus Recommendation

Sell-side recommendations on the ETF's individual constituents

Composite
BBP
Peer Average
SELL
U/W
HOLD
O/W
BUY



Recent Trends


Breakdown

 

Market Activity
Latest price
Change
Volume
Bid/Ask Spread
Update
Today's Trading

Trading data provided for free by IEX. By accessing this data you agree to abide by their Terms of Service.


Total Cost of Ownership (TCO) Comparison
Expense (bp)
(A)
Avg. Bid/Ask (bp)
(B)
TCO (bp)
(A)+(B)
BBP 79.0 25.7 104.7
Peer Avg. -- -- --
  For a detailed cost analysis of this and any other ETF use the TCO Comparison Tool .
Fundamental data for individual fund constituents sourced from FactSet Research Systems.